rs746514660
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_020745.4(AARS2):c.647dupG(p.Cys218LeufsTer6) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000917 in 1,613,962 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_020745.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- leukoencephalopathy, progressive, with ovarian failureInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Laboratory for Molecular Medicine
- mitochondrial diseaseInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- combined oxidative phosphorylation defect type 8Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
- hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented gliaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- ovarioleukodystrophyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AARS2 | NM_020745.4 | c.647dupG | p.Cys218LeufsTer6 | frameshift_variant | Exon 4 of 22 | ENST00000244571.5 | NP_065796.2 | |
AARS2 | XM_005249245.4 | c.647dupG | p.Cys218LeufsTer6 | frameshift_variant | Exon 4 of 20 | XP_005249302.1 | ||
AARS2 | XR_007059282.1 | n.671dupG | non_coding_transcript_exon_variant | Exon 4 of 14 | ||||
LOC124901322 | XR_007059594.1 | n.301-3054dupC | intron_variant | Intron 2 of 2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AARS2 | ENST00000244571.5 | c.647dupG | p.Cys218LeufsTer6 | frameshift_variant | Exon 4 of 22 | 1 | NM_020745.4 | ENSP00000244571.4 | ||
ENSG00000272442 | ENST00000505802.1 | n.*449+3455dupC | intron_variant | Intron 3 of 9 | 2 | ENSP00000424257.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152174Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000717 AC: 18AN: 251070 AF XY: 0.0000442 show subpopulations
GnomAD4 exome AF: 0.0000958 AC: 140AN: 1461788Hom.: 0 Cov.: 32 AF XY: 0.0000935 AC XY: 68AN XY: 727180 show subpopulations
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152174Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74330 show subpopulations
ClinVar
Submissions by phenotype
Combined oxidative phosphorylation defect type 8 Pathogenic:4
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. -
- -
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as pathogenic. Following criteria are met: 0102 - Loss of function is a likely mechanism of disease in this gene and is associated with combined oxidative phosphorylation deficiency 8 (MIM#614096) and leukoencephalopathy, progressive, with ovarian failure (MIM#615889) (PMIDs: 28633377, 30285085, 24808023). (I) 0106 - This gene is associated with autosomal recessive disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0304 - Variant is present in gnomAD (v2) <0.01 for a recessive condition (20 heterozygotes, 0 homozygotes). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity. At least nine NMD-predicted variants along AARS2 have been reported in affected individuals (ClinVar, Decipher, PMID: 31106991). (SP) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. This variant has been reported in individuals diagnosed with severe infantile cardiomyopathy, progressive leukoencephalopathy with ovarian failure and primary pulmonary hypoplasia (ClinVar; PMIDs: 25058219, 29971983, 30819764). (SP) 1007 - No published functional evidence has been identified for this variant. (I) 1201 - Heterozygous variant detected in trans with a second pathogenic heterozygous variant (NM_020745.4:c.1774C>T; p.(Arg592Trp)) in a recessive disease. (SP) 1205 - This variant has been shown to be maternally inherited. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
- -
not provided Pathogenic:3
- -
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 30819764, 34784527, 29971983, 34484863, 25058219) -
This sequence change creates a premature translational stop signal (p.Cys218Leufs*6) in the AARS2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in AARS2 are known to be pathogenic (PMID: 24808023, 30285085, 30819764). This variant is present in population databases (rs746514660, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with multiple respiratory chain complex defects (PMID: 25058219). This variant is also known as c.647_648insG. ClinVar contains an entry for this variant (Variation ID: 143044). For these reasons, this variant has been classified as Pathogenic. -
Pulmonary hypoplasia Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at